FindTrial
Sign In

Comparison of two medicines for controlling high parathyroid hormone levels in patients with kidney failure on dialysis

EFFICACY OF CINACALCET OR CALCITRIOL FOR TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS WITH CHRONIC KIDNEY DISEASE ON MAINTENANCE HAEMODIALYSIS: AN OPEN LABELLED RANDOMISED TRIAL - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100168
Enrollment
100
Registered
2026-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N186- End stage renal disease

Interventions

Intervention1: CINACALCET: The intervention to be given in patients with chronic kidney disease with maintenance hemodialysis with secondary hyperparathyroidism Control Intervention1: CALCITRIOL: The

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PTH more than 450 on MHD for 3 months

Exclusion criteria

Exclusion criteria: PTH more than 1900 Pregnant females

Design outcomes

Primary

MeasureTime frame
a. Serum PTH levels at baseline and at 24 weeks following initiation of medicationTimepoint: a. Serum PTH levels at baseline and at 24 weeks following initiation of medication—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactIshan Rohatgi

Sir Ganga Ram Hospital

bhallaak@yahoo.com9811047377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026